GSK gobbles debt for Novartis stake purchase
UK pharmaceutical firm GlaxoSmithKline has closed syndication on $13bn-equivalent of bridge loans to finance its purchase of Novartis’s stake in the two firms' consumer healthcare joint venture.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: